United States Iron Chelation Drug Market by Manufacturers, States, Type and Application, Forecast to 2022

Global Info Research
116 Pages
This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 1/4 g/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.


Scope of the Report:
This report focuses on the Iron Chelation Drug in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers
Apotex Inc. (Canada)
Cipla (India)
Novartis (Switzerland)
Sun Pharma (India)
Natco Pharma (India)

Market Segment by States, covering
California
Texas
New York
Florida
Illinois

Market Segment by Type, covers
Deferoxamine
Deferiprone
Deferasirox

Market Segment by Applications, can be divided into
Transfusional Iron Overload
NTDT Caused Iron Overload

There are 17 Chapters to deeply display the United States Iron Chelation Drug market.

Chapter 1, to describe Iron Chelation Drug Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Iron Chelation Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Iron Chelation Drug, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Iron Chelation Drug market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Iron Chelation Drug Research Findings and Conclusion, Appendix, methodology and data source.

Table of Contents
1 Market Overview
1.1 Iron Chelation Drug Introduction
1.2 Market Analysis by Type
1.2.1 Deferoxamine
1.2.2 Deferiprone
1.2.3 Deferasirox
1.3 Market Analysis by Applications
1.3.1 Transfusional Iron Overload
1.3.2 NTDT Caused Iron Overload
1.4 Market Analysis by States
1.4.1 California Status and Prospect (2012-2022)
1.4.2 Texas Status and Prospect (2012-2022)
1.4.3 New York Status and Prospect (2012-2022)
1.4.4 Florida Status and Prospect (2012-2022)
1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Apotex Inc. (Canada)
2.1.1 Profile
2.1.2 Iron Chelation Drug Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Apotex Inc. (Canada) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Apotex Inc. (Canada) News
2.2 Cipla (India)
2.2.1 Profile
2.2.2 Iron Chelation Drug Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Cipla (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Cipla (India) News
2.3 Novartis (Switzerland)
2.3.1 Profile
2.3.2 Iron Chelation Drug Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novartis (Switzerland) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Novartis (Switzerland) News
2.4 Sun Pharma (India)
2.4.1 Profile
2.4.2 Iron Chelation Drug Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Sun Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Sun Pharma (India) News
2.5 Natco Pharma (India)
2.5.1 Profile
2.5.2 Iron Chelation Drug Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Natco Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Natco Pharma (India) News
3 United States Iron Chelation Drug Market Competition, by Manufacturer
3.1 United States Iron Chelation Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Iron Chelation Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Iron Chelation Drug Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Iron Chelation Drug Manufacturer Market Share
3.4.2 Top 5 Iron Chelation Drug Manufacturer Market Share
3.5 Market Competition Trend
4 United States Iron Chelation Drug Market Analysis by States
4.1 United States Iron Chelation Drug Sales Market Share by States
4.2 United States Iron Chelation Drug Sales by States (2012-2017)
4.3 United States Iron Chelation Drug Revenue (Value) by States (2012-2017)
5 United States Market Segmentation Iron Chelation Drug by Type
5.1 United States Iron Chelation Drug Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 United States Iron Chelation Drug Sales and Market Share by Type (2012-2017)
5.1.2 United States Iron Chelation Drug Revenue and Market Share by Type (2012-2017)
5.2 Deferoxamine Sales Growth and Price
5.2.1 United States Deferoxamine Sales Growth (2012-2017)
5.2.2 United States Deferoxamine Price (2012-2017)
5.3 Deferiprone Sales Growth and Price
5.3.1 United States Deferiprone Sales Growth (2012-2017)
5.3.2 United States Deferiprone Price (2012-2017)
5.4 Deferasirox Sales Growth and Price
5.4.1 United States Deferasirox Sales Growth (2012-2017)
5.4.2 United States Deferasirox Price (2012-2017)
6 United States Market Segmentation Iron Chelation Drug by Application
6.1 United States Iron Chelation Drug Sales Market Share by Application (2012-2017)
6.2 Transfusional Iron Overload Sales Growth (2012-2017)
6.3 NTDT Caused Iron Overload Sales Growth (2012-2017)
7 California Iron Chelation Drug Sales, Revenue, by Type, Application and Manufacturers
7.1 California Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)
7.2 California Iron Chelation Drug Sales and Market Share by Type
7.3 California Iron Chelation Drug Sales by Application (2012-2017)
8 New York Iron Chelation Drug Sales, Revenue, by Type, Application and Manufacturers
8.1 New York Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Iron Chelation Drug Sales and Market Share by Type
8.3 New York Iron Chelation Drug Sales by Application (2012-2017)
9 Texas Iron Chelation Drug Sales, Revenue, by Type, Application and Manufacturers
9.1 Texas Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Iron Chelation Drug Sales and Market Share by Type
9.3 Texas Iron Chelation Drug Sales by Application (2012-2017)
10 Florida Iron Chelation Drug Sales, Revenue, by Type, Application and Manufacturers
10.1 Florida Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Iron Chelation Drug Sales and Market Share by Type
10.3 Florida Iron Chelation Drug Sales by Application (2012-2017)
11 Illinois Iron Chelation Drug Sales, Revenue, by Type, Application and Manufacturers
11.1 Illinois Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Iron Chelation Drug Sales and Market Share by Type
11.3 Illinois Iron Chelation Drug Sales by Application (2012-2017)
12 Iron Chelation Drug Market Forecast (2017-2022)
12.1 United States Iron Chelation Drug Sales, Revenue and Growth Rate (2017-2022)
12.2 Iron Chelation Drug Market Forecast by States (2017-2022)
12.3 Iron Chelation Drug Market Forecast by Type (2017-2022)
12.4 Iron Chelation Drug Market Forecast by Application (2017-2022)
13 Iron Chelation Drug Manufacturing Cost Analysis
13.1 Iron Chelation Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Iron Chelation Drug
14 Industrial Chain, Sourcing Strategy and Downstream Buyers
14.1 Iron Chelation Drug Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Iron Chelation Drug Major Manufacturers in 2016
14.4 Downstream Buyers
15 Sales Channel, Distributors, Traders and Dealers
15.1 Sales Channel
15.1.1 Direct Marketing
15.1.2 Indirect Marketing
15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source


List of Tables and Figures

Figure Iron Chelation Drug Picture
Table Product Specifications of Iron Chelation Drug
Figure United States Sales Market Share of Iron Chelation Drug by Types in 2016
Table Types of Iron Chelation Drug
Figure Deferoxamine Picture
Table Major Manufacturers of Deferoxamine
Figure Deferiprone Picture
Table Major Manufacturers of Deferiprone
Figure Deferasirox Picture
Table Major Manufacturers of Deferasirox
Table United States Iron Chelation Drug Sales Market Share by Applications in 2016
Table Applications of Iron Chelation Drug
Figure Transfusional Iron Overload Picture
Figure NTDT Caused Iron Overload Picture
Figure California Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)
Table Apotex Inc. (Canada) Basic Information, Manufacturing Base and Competitors
Table Apotex Inc. (Canada) Iron Chelation Drug Type and Applications
Table Apotex Inc. (Canada) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cipla (India) Basic Information, Manufacturing Base and Competitors
Table Cipla (India) Iron Chelation Drug Type and Applications
Table Cipla (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis (Switzerland) Basic Information, Manufacturing Base and Competitors
Table Novartis (Switzerland) Iron Chelation Drug Type and Applications
Table Novartis (Switzerland) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharma (India) Basic Information, Manufacturing Base and Competitors
Table Sun Pharma (India) Iron Chelation Drug Type and Applications
Table Sun Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Natco Pharma (India) Basic Information, Manufacturing Base and Competitors
Table Natco Pharma (India) Iron Chelation Drug Type and Applications
Table Natco Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Iron Chelation Drug Sales by Manufacturer (2016-2017)
Figure United States Iron Chelation Drug Sales Market Share by Manufacturer in 2016
Figure United States Iron Chelation Drug Sales Market Share by Manufacturer in 2017
Table United States Iron Chelation Drug Revenue by Manufacturer (2016-2017)
Figure United States Iron Chelation Drug Revenue Market Share by Manufacturer in 2015
Figure United States Iron Chelation Drug Revenue Market Share by Manufacturer in 2016
Table United States Iron Chelation Drug Price by Manufacturers (2016-2017)
Figure Top 3 Iron Chelation Drug Manufacturer Market Share in 2016
Figure Top 3 Iron Chelation Drug Manufacturer Market Share in 2017
Figure Top 5 Iron Chelation Drug Manufacturer Market Share in 2016
Figure Top 5 Iron Chelation Drug Manufacturer Market Share in 2017
Figure United States Iron Chelation Drug Sales and Growth (2012-2017)
Table United States Iron Chelation Drug Sales by States (2012-2017)
Table United States Iron Chelation Drug Sales Market Share by States (2012-2017)
Figure United States 2012 Iron Chelation Drug Sales Market Share by States
Figure United States 2016 Iron Chelation Drug Sales Market Share by States
Figure United States Iron Chelation Drug Revenue and Growth (2012-2017)
Table United States Iron Chelation Drug Revenue by States (2012-2017)
Table United States Iron Chelation Drug Revenue Market Share by States (2012-2017)
Table United States 2012 Iron Chelation Drug Revenue Market Share by States
Table United States 2016 Iron Chelation Drug Revenue Market Share by States
Table United States Iron Chelation Drug Sales by Type (2012-2017)
Table United States Iron Chelation Drug Sales Share by Type (2012-2017)
Table United States Iron Chelation Drug Revenue by Type (2012-2017)
Table United States Iron Chelation Drug Revenue Share by Type (2012-2017)
Figure United States Deferoxamine Sales Growth (2012-2017)
Figure United States Deferoxamine Price (2012-2017)
Figure United States Deferiprone Sales Growth (2012-2017)
Figure United States Deferiprone Price (2012-2017)
Figure United States Deferasirox Sales Growth (2012-2017)
Figure United States Deferasirox Price (2012-2017)
Table United States Iron Chelation Drug Sales by Application (2012-2017)
Table United States Iron Chelation Drug Sales Share by Application (2012-2017)
Figure United States Transfusional Iron Overload Sales Growth (2012-2017)
Figure United States NTDT Caused Iron Overload Sales Growth (2012-2017)
Figure California Iron Chelation Drug Revenue and Growth (2012-2017)
Figure California Iron Chelation Drug Sales and Growth (2012-2017)
Table California Iron Chelation Drug Sales by Type (2012-2017)
Table California Iron Chelation Drug Sales Market Share by Type (2012-2017)
Table California Iron Chelation Drug Sales by Application (2012-2017)
Table California Iron Chelation Drug Sales Market Share by Application (2012-2017)
Figure New York Iron Chelation Drug Revenue and Growth (2012-2017)
Figure New York Iron Chelation Drug Sales and Growth (2012-2017)
Table New York Iron Chelation Drug Sales by Type (2012-2017)
Table New York Iron Chelation Drug Sales Market Share by Type (2012-2017)
Table New York Iron Chelation Drug Sales by Application (2012-2017)
Table New York Iron Chelation Drug Sales Market Share by Application (2012-2017)
Figure Texas Iron Chelation Drug Revenue and Growth (2012-2017)
Figure Texas Iron Chelation Drug Sales and Growth (2012-2017)
Table Texas Iron Chelation Drug Sales by Type (2012-2017)
Table Texas Iron Chelation Drug Sales Market Share by Type (2012-2017)
Table Texas Iron Chelation Drug Sales by Application (2012-2017)
Table Texas Iron Chelation Drug Sales Market Share by Application (2012-2017)
Figure Florida Iron Chelation Drug Revenue and Growth (2012-2017)
Figure Florida Iron Chelation Drug Sales and Growth (2012-2017)
Table Florida Iron Chelation Drug Sales by Type (2012-2017)
Table Florida Iron Chelation Drug Sales Market Share by Type (2012-2017)
Table Florida Iron Chelation Drug Sales by Application (2012-2017)
Table Florida Iron Chelation Drug Sales Market Share by Application (2012-2017)
Figure Illinois Iron Chelation Drug Revenue and Growth (2012-2017)
Figure Illinois Iron Chelation Drug Sales and Growth (2012-2017)
Table Illinois Iron Chelation Drug Sales by Type (2012-2017)
Table Illinois Iron Chelation Drug Sales Market Share by Type (2012-2017)
Table Illinois Iron Chelation Drug Sales by Application (2012-2017)
Table Illinois Iron Chelation Drug Sales Market Share by Application (2012-2017)
Figure United States Iron Chelation Drug Sales, Revenue and Growth Rate (2017-2022)
Table United States Iron Chelation Drug Sales Forecast by States (2017-2022)
Table United States Iron Chelation Drug Market Share Forecast by States (2017-2022)
Table United States Iron Chelation Drug Sales Forecast by Type (2017-2022)
Table United States Iron Chelation Drug Market Share Forecast by Type (2017-2022)
Table United States Iron Chelation Drug Sales Forecast by Application (2017-2022)
Table United States Iron Chelation Drug Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Iron Chelation Drug
Figure Manufacturing Process Analysis of Iron Chelation Drug
Figure Iron Chelation Drug Industrial Chain Analysis
Table Raw Materials Sources of Iron Chelation Drug Major Manufacturers in 2016
Table Major Buyers of Iron Chelation Drug
Table Distributors/Traders/ Dealers List

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Vinylphosphonic Acid Market 2018 Forecast to 2023

GIR 2018-05-21 Chemical & Materials

Vinylphosphonic acid is an organophosphorus compound with the formula C2H3PO3H2. It is a colorless l...Read More

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) VAE Emulsion Market 2018 Forecast to 2023

GIR 2018-05-21 Chemical & Materials

This report studies the VAE Emulsion market, vinyl acetate ethylene (VAE) emulsions are based on the...Read More

Report's License Type

$4480
$8960

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.